ANTINEOPLASTIC ALKYLATING DRUGS
\ˌantɪnˌiːə͡ʊplˈastɪk ˈalkɪlˌe͡ɪtɪŋ dɹˈʌɡz], \ˌantɪnˌiːəʊplˈastɪk ˈalkɪlˌeɪtɪŋ dɹˈʌɡz], \ˌa_n_t_ɪ_n_ˌiː__əʊ_p_l_ˈa_s_t_ɪ_k ˈa_l_k_ɪ_l_ˌeɪ_t_ɪ_ŋ d_ɹ_ˈʌ_ɡ_z]\
Sort: Oldest first
-
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)
By DataStellar Co., Ltd
Nearby Words
- antinematodals
- antineoplastic
- antineoplastic agent resistance
- antineoplastic agents
- antineoplastic alkylating agents
- Antineoplastic Alkylating Drugs
- antineoplastic and immunosuppressive agents
- antineoplastic antibiotic
- antineoplastic antibiotics
- antineoplastic antimetabolites
- antineoplastic chemotherapy protocol